![Wolfram Dempke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Wolfram Dempke
Hoofd Techniek/Wetenschap/O&O bij
CANTARGIA AB
Profiel
Wolfram Dempke currently works at Cantargia AB, as Chief Medical Officer from 2025 and Ludwig-Maximilians-Universität München, as Professor.
Dr. Dempke received his doctorate degree from the University of London and doctorate degree from the University of Duisburg-Essen.
Actieve functies van Wolfram Dempke
| Bedrijven | Functie | Begin |
|---|---|---|
| CANTARGIA AB | Hoofd Techniek/Wetenschap/O&O | 02-10-2025 |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Opleiding van Wolfram Dempke
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
12
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Duisburg-Essen
 University of Duisburg-Essen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ludwig-Maximilians-Universität München
Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cantargia AB
 Cantargia AB Pharmaceuticals: MajorHealth Technology Creates and develops antibody therapeutics for the treatment of leukemia | Health Technology |
